OTC Reporter New Spotlight Stock - MBHS

Our New Spotlight Stock is… MBHS
 
 

Here is a new and exciting company for you to put on your watch-list, MBHS!

MBHS was just acquired by a revolutionary Skin Cancer detection company.  This may take the company to a whole new level.

As of July 13, 2010, mBeach Software, Inc. was acquired by Skin Cancer Scanning Ltd. in a reverse merger transaction. http://finance.yahoo.com/news/mBeach-Software-Inc-Finalizes-pz-2761523180.html?x=0&.v=1

Skin Cancer Scanning Ltd. (SCS) is a medical device company pioneering the development and commercialization of a revolutionary and proprietary imaging system for the early detection and diagnosis of skin cancer.

Check out their web-site: www.scs-med.com.

Annual rates of skin cancer are increasing each year, representing a growing public concern.

According to the American Academy of Dermatology, more than two million cases of skin cancer are diagnosed in the United States each year.

Just last week, the company issued a stockholder update on the growing market for skin cancer diagnostic solutions. http://finance.yahoo.com/news/Mbeach-Software-Inc-Targeting-pz-3714269292.html?x=0&.v=1

Their product, SkinScan 650, is a non-invasive, point-of-care (in the doctor's office) system to detect and identify different kinds of skin nevi, tumors, lesions and cancers.

This product will reduce the number of biopsies, lower treatment costs, and improve quality of life.

MBHS could be a steal at its current level.  As more people find out about this acquisition, stock could be trading at a much higher level!

 


















OTCReporter.com, HotOTCChina.com, OTCPennystockreporter.com, OTCPennypicks.com, and Chartpenny.com (the “Websites”) are owned by Oceanic Consulting, LLC ("Oceanic") and Garden State Resources NJ, LLC ("Garden State") (Oceanic and Garden State are collectively referred to herein as the "LLC Companies) , both of which are New Jersey limited liability corporations (the Websites and its owners, the LLC Companies, and their affiliates, directors and officers and its immediate family members are referred to in our Disclaimer as "OTCR" or "we" or "us" or "our").  Because we receive monetary or securities compensation most often in the form of common stock (hereafter referred to as the "Shares") for our dissemination of publicly disseminated information (the “Information”) regarding various issuers of securities, we disclose our specific compensation herein and in our individual reports of profiled issuers. The LLC Companies received forty thousand dollars from a non-affiliate third party shareholder of  MBHS Skin Cancer Scanning Ltd. in return for OTCR’s services to publicly and electronically disseminate information pertaining to Skin Cancer Scanning Ltd.  It is imperative that all readers of the above compenstations disclosure carefully review our Disclaimer in its entirety, which contains important information about penny stocks, our operations, the limited nature of the Information and various risks attendant to the companies that we profile, including that: (a) we receive our compensation in free trading shares, which we will sell immediately upon their receipt as well as during the dissemination of such Information or within hours, days, weeks or months thereafter, or at any time; as a result, our selling activities will cause significant volatility in the Issuer’s stock price and/or significantly depress the Issuer’s stock price; (b) we will buy and sell the Shares in the open market before, during or after the dissemination of the Information or at any time, which will cause significant volatility in the Issuer’s stock price and/or significantly depress or increase the Issuer’s stock price; (c) there is an inherent and actual conflict of interest that exists between our Readers’ interests and our interests because we: (i) receive the Shares  as compensation for disseminating the Information and thereafter sell those Shares at any time for monetary gain, including at the same time the Information is being disseminated or shortly thereafter or at any time; and (ii) buy and sells the Profiled Company’s shares in the open market at the same time or before the Information is being disseminated or shortly after the dissemination of the Information or at any time. Our gains from sale of the Shares may be substantial.   
 
Click to read our disclaimer



This message was sent from OTCReporter to bigalerts2@gmail.com. It was sent from: OTCReporter.com, P.O. Box 273, Rumson, NJ 07760. You can modify/update your subscription via the link below.

Email Marketing by
iContact - Try It Free!


Manage your subscription